Trending News
News
News
UT Southwestern Researchers Discover Brain's Memory 'Buffer' in Single Cells
The study identifies the specific signal that establishes nonpermanent cellular memory and reveals how the brain holds temporary information.
News
QIAGEN Announces New President for QIAGEN Japan
Stephane Perrey brings strong life science and molecular diagnostics background to QIAGEN.
News
SickKids Selects GenoLogics for an Integrated Lab and Data Management Solution
The Centre for Applied Genomics at SickKids is deploying GenoLogics lab and data management solution across multiple facilities of its genome centre.
News
DNA Component Can Stimulate and Suppress the Immune Response
Researchers find a component of DNA that can both stimulate and suppress the immune system and may hold hope for treating cancer and infection.
News
CLC bio Bridges Digital and Analogue Gene Expression with new Version of CLC Genomics Workbench
The new version 3.0 features digital gene expression, expression analysis of micro arrays and RNA-seq data.
News
Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
Web portal provides access to library of life science research and enables experiment modeling.
News
Experimental Topical Microbicide Offers Long-Lasting Protection Against Genital Herpes Libraries
A topical microbicide that silences two genes can safely protect against genital herpes infection for as long as one week, according to Einstein researchers.
News
QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents
Rotor-Gene™ Q now fully “Licensed Real-Time Thermal Cycler” for all molecular research and diagnostic applications.
News
GeneBio and Utrecht University Announce Collaborative Partnership Around Phenyx
University’s Heck Laboratory will utilize GeneBio’s Phenyx software platform in order to get optimized scorings for its Lys-N protein digestion workflow.
News
Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Geron Corporation announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
Advertisement